[接受拉米夫定与乙型肝炎免疫球蛋白联合预防性治疗的肝移植受者外周血单个核细胞及骨髓CD34+细胞中HBV DNA滴度及复制情况的检测] - Suppr | 超能文献

[Detection of titers and replications of HBV DNA in peripheral blood mononuclear cells and bone marrow CD34+ cells in liver transplant recipients receiving prophylactic combined lamivudine and hepatitis B immunoglobulin treatments].

作者信息

Lai Wei, Lu Shi-Chun, Li You-Ping, Zhao Ji, Dai Jun, Jin Sheng-Jie

机构信息

West China Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2007 Nov;15(11):852-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Detection of titers and replications of HBV DNA in peripheral blood mononuclear cells and bone marrow CD34+ cells in liver transplant recipients receiving prophylactic combined lamivudine and hepatitis B immunoglobulin treatments].[接受拉米夫定与乙型肝炎免疫球蛋白联合预防性治疗的肝移植受者外周血单个核细胞及骨髓CD34+细胞中HBV DNA滴度及复制情况的检测]

Zhonghua Gan Zang Bing Za Zhi. 2007 Nov;15(11):852-3.

2

Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.接受拉米夫定治疗的肝移植受者体内的残余乙肝病毒颗粒：乙肝病毒DNA的PCR定量及前S1抗原的ELISA检测

J Med Virol. 2001 Nov;65(3):493-504.

3

Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.拉米夫定对肝移植前后乙型肝炎病毒前C区变异感染患者的疗效

Am J Gastroenterol. 1999 Mar;94(3):663-7. doi: 10.1111/j.1572-0241.1999.00933.x.

4

Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.在活体肝移植中使用乙肝免疫球蛋白和拉米夫定预防来自乙肝核心抗体阳性供体移植物的乙肝病毒感染。

Liver Int. 2005 Dec;25(6):1169-74. doi: 10.1111/j.1478-3231.2005.01165.x.

5

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.阿德福韦酯治疗肝移植受者中尽管使用拉米夫定加乙肝免疫球蛋白预防仍出现的乙肝病毒感染复发情况。

J Gastroenterol Hepatol. 2007 Dec;22(12):2130-4. doi: 10.1111/j.1440-1746.2006.04609.x.

6

Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.肝移植后联合使用乙肝免疫球蛋白和拉米夫定进行预防，可将乙肝复发率降至最低，除非移植前出现拉米夫定耐药。

Z Gastroenterol. 2002 Sep;40(9):795-9. doi: 10.1055/s-2002-33874.

7

Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.在一名等待肝移植的拉米夫定耐药乙型肝炎病毒C型肝硬化儿童患者中，使用替诺福韦治疗成功。移植后结果。

Transpl Int. 2005 Jul;18(7):879-83. doi: 10.1111/j.1432-2277.2005.00125.x.

8

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.肝移植后拉米夫定单药预防乙型肝炎病毒复发中与病毒突破相关的因素。

J Med Virol. 2002 Oct;68(2):182-7. doi: 10.1002/jmv.10185.

9

Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.肝移植后预防性使用低剂量、按需肌肉注射乙型肝炎免疫球蛋白和拉米夫定。

Transplant Proc. 2006 Mar;38(2):579-83. doi: 10.1016/j.transproceed.2005.12.063.

10

Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.长期拉米夫定单药治疗可预防乙肝核心抗体阳性供体的乙肝表面抗原阴性肝移植受者发生乙肝病毒感染。

Clin Transplant. 2006 May-Jun;20(3):369-73. doi: 10.1111/j.1399-0012.2006.00495.x.

引用本文的文献

1

Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease.HBV 相关终末期肝病肝移植后主动免疫对 HBV 移植肝再感染的重建。

J Immunol Res. 2014;2014:764234. doi: 10.1155/2014/764234. Epub 2014 Dec 17.